Skip to search formSkip to main contentSkip to account menu

Trimebutine

Known as: Benzoic acid, 3,4,5-trimethoxy-, 2-(dimethylamino)-2-phenylbutyl ester, Trimebutine [Chemical/Ingredient] 
Proposed spasmolytic with possible local anesthetic action used in gastrointestinal disorders.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Irritable bowel syndrome (IBS) is a functional disorder characterized by chronic or recurrent abdominal pain or discomfort with… 
2006
2006
BACKGROUND AND AIM Irritable bowel syndrome (IBS) is a harassing condition leading to the impairment of the quality of life… 
2002
2002
BACKGROUND/AIMS GERD (gastroesophageal reflux disease) occurs in 25-51% of IBS (irritable bowel syndrome) patients. Trimebutine… 
1991
1991
The pharmacological profile of bethanechol (CAS 674-38-4), metoclopramide (CAS 364-62-5), trimebutine (CAS 39133-31-8) and… 
1984
1984
The effects of intravenous (i.v.) vs intracerebroventricular (i.c.v.) administration of trimebutine on the motility of the small… 
1980
1980
Indigestion, flatulent dyspepsia, nausea, vomiting, abdominal pain or discomfort are among the commonest complaints in adults…